Terns Pharmaceuticals Cash Flow Statement (2020-2025) | TERN

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-13.34M-10.74M-11.84M35.57M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.04M-22.37M-22.74M-21.95M67.21M-23.91M-24.09M-24.64M-23.22M
Share-based Compensation (Quarter)
1.83M1.91M1.85M2.55M2.74M2.65M2.69M2.69M3.94M4.23M14.08M3.28M4.03M4.42M4.16M3.02M3.68M3.03M3.34M3.35M
Gains from Sales and Divestitures (Quarter)
0.07M0.07M0.07M0.03M0.03M0.05M0.07M0.10M0.14M0.16M0.13M0.17M0.21M0.15M
Gains from Investment Securities (Quarter)
2.27M0.14M1.51M1.39M1.11M-0.01M0.28M8.30M0.15M11.37M2.82M-1.22M0.10M0.24M5.41M
Non-cash Items (Quarter)
2.01M9.87M1.86M0.49M28.40M0.30M0.30M11.72M2.81M6.75M0.92M2.23M3.13M5.74M5.78M23.40M5.72M5.70M6.00M2.04M
Cash from Operations (Quarter)
-14.32M-8.76M-8.08M-10.67M-13.30M-11.16M-13.44M-11.21M-14.38M-12.99M-20.70M-19.32M-22.80M-16.18M-16.45M-14.58M-24.44M-18.88M-19.77M-19.08M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.14M0.13M0.14M0.14M0.15M0.14M0.15M0.15M0.15M0.15M0.12M0.15M0.11M0.10M0.10M0.10M
Amortization of Deferred Charges (Quarter)
-0.00M0.15M0.54M0.19M0.61M0.06M-0.03M-0.57M-0.81M-0.97M-1.75M-1.68M-0.92M-0.61M-0.37M-0.20M-0.11M-0.03M0.01M0.07M
Depreciation & Amortization (CF) (Quarter)
0.17M0.12M0.11M0.11M0.14M0.14M0.11M0.09M0.08M0.07M0.07M0.07M0.08M0.09M0.08M0.07M0.06M0.01M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter)
2.21M-0.88M-0.11M0.51M-0.41M-0.70M0.86M-0.47M1.32M2.85M-2.21M-0.81M-0.81M0.17M-0.14M0.41M0.63M0.07M0.10M-1.31M
Change in Accured Expenses (Quarter)
-3.94M0.01M1.18M-0.62M-0.73M0.58M0.21M1.35M2.67M-0.71M0.01M0.77M-2.12M2.13M0.25M3.98M-5.34M1.89M2.36M1.72M
Other Working Capital Changes (Quarter)
-0.01M0.01M0.38M-0.63M-0.15M-0.15M2.60M-1.18M0.07M-0.39M2.11M-2.45M1.25M-1.60M0.09M0.22M-0.11M-0.41M0.21M-0.11M
Investing Activities
Capital Expenditures (Quarter)
0.02M0.04M0.07M0.20M0.24M0.01M-0.01M0.03M0.01M0.04M0.03M0.01M
Change in Acquisitions & Divestments (Quarter)
19.94M13.50M13.50M34.16M22.07M28.00M33.50M51.79M91.99M41.77M52.29M58.62M42.20M31.75M25.00M27.00M25.50M24.50M30.00M
Cash from Investing Activities (Quarter)
-96.82M-20.90M4.44M-6.42M9.49M-15.97M-1.24M-14.55M27.93M-90.84M-22.31M47.23M8.00M42.19M31.75M-94.35M1.96M25.50M24.50M-350.00M
Financing Activities
Other financing activities (Quarter)
1.03M1.69M0.14M0.26M0.34M0.07M0.31M0.01M0.23M
Cash from Financing Activities (Quarter)
135.17M-1.59M0.80M0.02M0.12M61.00M105.97M27.58M0.49M0.02M13.86M0.40M163.29M0.30M0.07M0.32M743.12M
Additional items
Exchange Rate Effect (Quarter)
-0.06M0.01M0.00M0.02M-0.01M-0.06M-0.15M0.04M-0.01M-0.09M-0.03M0.26M-0.03M-0.01M0.05M-0.07M-0.00M-0.00M0.01M0.01M
Change in Cash (Quarter)
23.98M-31.24M-2.84M-17.05M-3.82M-27.07M46.17M80.26M41.12M-103.44M-43.03M42.03M-14.83M26.40M178.64M-108.70M-22.42M6.94M4.73M374.05M
Free Cash Flow (Quarter)
-14.34M-8.80M-8.16M-10.87M-13.54M-11.17M-13.43M-11.24M-14.38M-12.99M-20.71M-19.36M-22.83M-16.19M-16.45M-14.58M-24.44M-18.88M-19.77M-19.08M
Net Cash Flow (Quarter)
24.04M-31.25M-2.84M-17.07M-3.81M-27.01M46.33M80.21M41.13M-103.34M-42.99M41.78M-14.80M26.41M178.59M-108.63M-22.41M6.94M4.73M374.03M